Cleared Special

SLEUTH IMPLANTABLE ECG SYSTEM-8 CM ACCESSORY KIT, MODEL 3000-08 (K073147) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
25d
Days
Class 2
Risk

K073147 is an FDA 510(k) clearance for the SLEUTH IMPLANTABLE ECG SYSTEM-8 CM ACCESSORY KIT, MODEL 3000-08. Classified as Recorder, Event, Implantable Cardiac, (without Arrhythmia Detection) (product code MXC), Class II - Special Controls.

Submitted by Transoma Medical (Arden Hills, US). The FDA issued a Cleared decision on December 3, 2007 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Transoma Medical devices

Submission Details

510(k) Number K073147 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2007
Decision Date December 03, 2007
Days to Decision 25 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 125d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MXC Recorder, Event, Implantable Cardiac, (without Arrhythmia Detection)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MXC Recorder, Event, Implantable Cardiac, (without Arrhythmia Detection)

All 22
Devices cleared under the same product code (MXC) and FDA review panel - the closest regulatory comparables to K073147.
Assert-IQ™ Insertable Cardiac Monitor
K230286 · Abbott Medical · May 2023
Jot Dx Insertable Cardiac Monitor
K212206 · Abbott (St. Jude Medical) · Aug 2021
Confirm Rx Insertable Cardiac Monitor
K202876 · Abbott (St. Jude Medical) · Dec 2020
Confirm Rx Insertable Cardiac Monitor
K202888 · Abbott (St. Jude Medical) · Nov 2020
myMerlin Mobile Application (Android), myMerlin Mobile Application (iOS)
K193310 · Abbott (St. Jude Medical) · Mar 2020
Confirm Rx Insertable Cardiac Monitor
K192593 · Abbott · Oct 2019